Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 23, 17 Issues, 2022
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets , Volume 19 - Number 7





Review Article

Biologic therapies in ulcerative colitis: primi inter pares?

, 19(7): 748 - 756

Mariangela Allocca, Gionata Fiorino, Daniela Gilardi, Paoletta Preatoni, Alfredo Papa, Laurent Peyrin-Biroulet and Silvio Danese*


DOI: 10.2174/1389450117666160527142719






Review Article

Can Surgery for Inflammatory Bowel Disease be Personalized?

, 19(7): 798 - 804

Antonino Spinelli*, Alessandra Marano, Claudio Bacchelli, Nicolo Maria Mariani, Marco Montorsi and Paulo Gustavo Kotze


DOI: 10.2174/1389450118666170105153646






Review Article

Main Isoflavones Found in Dietary Sources as Natural Anti-inflammatory Agents

, 19(7): 841 - 853

Corina Danciu*, Stefana Avram, Ioana Zinuca Pavel, Roxana Ghiulai, Cristina Adriana Dehelean, Alexa Ersilia, Daliana Minda, Cristina Petrescu*, Elena-Alina Moaca and Codruta Soica


DOI: 10.2174/1389450118666171109150731



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog